Health / Medical Topics

    Enteric-Coated Zoledronic Acid Tablet MER-101

    An oral tablet formulation containing zoledronic acid combined with a proprietary absorption enhancer for improved zoledronic acid gastrointestinal absorption with anti-bone-resorption activity. The third-generation bisphosphonate zoledronic acid binds to hydroxyapatite crystals in the bone matrix, slowing their dissolution and inhibiting the formation and aggregation of these crystals. This agent also inhibits farnesyl pyrophosphate synthase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. The proprietary absorption enhancer is a GRAS (generally-recognized-as-safe) food additive. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    An enteric-coated orally bioavailable formulation of the hydrochloride salt of a small-molecule agonist for transient receptor potential melastatin member 8 (TRPM8 or…
    A tablet covered with a substance that is designed to delay the release of active and/or inert ingredient(s) until the tablet passes…
    A capsule covered with a substance that is designed to delay the release of active and/or inert ingredient(s) until the capsule passes…
    Having made a record of, set down in permanent form, or formally registered to participate in an activity.
    Administration of a substance by the way of the gastrointestinal tract, usually for systemic action. Drug bioavailability can be affected due to…
    A form of nutrition that is delivered into the digestive system as a liquid. Drinking nutrition beverages or formulas and tubefeeding are…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact